NPPB and COVID-19: By excluding ER cases (n = 216,705), results were similar to that of the main analysis with moderate to severe liver disease, renal disease, and metastatic solid tumor being the leading fatal comorbidities, and elevated procalcitonin, NT proBNP, and ferritin being the top biomarkers related to COVID-19 death (Supplemental Fig. 5).